T80.82XD: Complication of immune effector cellular therapy, subsequent encounter
T80.82XD is a billable, specific ICD-10-CM code for complication of immune effector cellular therapy, subsequent encounter. It is valid for submission on a claim.
Check T80.82XD with the rest of the claim: free scrubber7th character "D": subsequent encounter
The appropriate 7th character is to be added to each code from category T80
- A
- initial encounter
- D
- subsequent encounter
- S
- sequela
Excludes2: not included here, but may coexist
The excluded condition is not part of this code, but a patient can have both. You may code both.
Use additional code
Add a secondary code to capture the detail described below.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Complication of chimeric antigen receptor (CAR-T) cell therapy
- Complication of IEC therapy
Excludes2 inherited from the categories above T80.82XD
Not part of this code, but both may be coded when both are present.
Written on T80.82: Complication of immune effector cellular therapy
Written on T80: Complications following infusion, transfusion and therapeutic injection
- bone marrow transplant rejection (T86.01)
- febrile nonhemolytic transfusion reaction (R50.84)
- fluid overload due to transfusion (E87.71)
- posttransfusion purpura (D69.51)
- transfusion associated circulatory overload (TACO) (E87.71)
- transfusion (red blood cell) associated hemochromatosis (E83.111)
- transfusion related acute lung injury (TRALI) (J95.84)
Risk adjustment
No CMS-HCC V28 category: this code does not change a RAF score.
Code history
Unchanged in every release from FY2024 to FY2027.